A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).
Felice, C., Lewis, A., Armuzzi, A., Lindsay, J., Silver, A., Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases, <<ALIMENTARY PHARMACOLOGY & THERAPEUTICS>>, 2015; 41 (1): 26-38. [doi:10.1111/apt.13008] [http://hdl.handle.net/10807/64558]
Autori: | |
Titolo: | Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases |
Digital Object Identifier (DOI): | http://dx.doi.org/10.1111/apt.13008 |
Data di pubblicazione: | 2014 |
Abstract: | A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD). |
Lingua: | Inglese |
Rivista: | |
Citazione: | Felice, C., Lewis, A., Armuzzi, A., Lindsay, J., Silver, A., Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases, <<ALIMENTARY PHARMACOLOGY & THERAPEUTICS>>, 2015; 41 (1): 26-38. [doi:10.1111/apt.13008] [http://hdl.handle.net/10807/64558] |
Appare nelle tipologie: | Articolo in rivista, Nota a sentenza |
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.